An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease

The 2018 US Kidney Data System report shows that more than 30 million US adults may suffer from chronic kidney disease(CKD),and cardiovascular disease(CVD)is the main cause of death from chronic renal failure.Therefore,early identification of clinical manifestations of CVD and early intervention in...

Full description

Saved in:
Bibliographic Details
Main Authors: WANG Xiao-yu, XU Mi-qing
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2020-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57906140&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849323478564470784
author WANG Xiao-yu
XU Mi-qing
author_facet WANG Xiao-yu
XU Mi-qing
author_sort WANG Xiao-yu
collection DOAJ
description The 2018 US Kidney Data System report shows that more than 30 million US adults may suffer from chronic kidney disease(CKD),and cardiovascular disease(CVD)is the main cause of death from chronic renal failure.Therefore,early identification of clinical manifestations of CVD and early intervention in CVD are of vital importance.Cardiac biomarkers,such as B-type natriuretic peptide(BNP)and N-terminal pro-B-type natriuretic peptide(NT-proBNP),are commonly used to diagnose congestive heart failure(CHF)in symptomatic patients.There is sufficient evidence that these biomarkers can be used to assess the severity of the disease and its prognosis.However,in CKD patients,because the decrease of renal clearance rate may affect the plasma level of these biomarkers,BNP faces challenges in diagnosis utility and prognosis evaluation.It is difficult to distinguish cardiac-induced heart failure from renal-induced chronic BNP elevation in non-dialysis CKD patients.This review reviews the physiological functions of the natriuretic peptide BNP in detail,and briefly discusses the characteristics of CVD in a non-dialysis CKD population,the changes of BNP,influencing factors and possible mechanisms,and its predictive significance for CVD.
format Article
id doaj-art-4a8b0010d84e469bbd752679e3ab073b
institution Kabale University
issn 1671-2390
language zho
publishDate 2020-01-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
series Linchuang shenzangbing zazhi
spelling doaj-art-4a8b0010d84e469bbd752679e3ab073b2025-08-20T03:49:02ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902020-01-012050851257906140An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney diseaseWANG Xiao-yuXU Mi-qingThe 2018 US Kidney Data System report shows that more than 30 million US adults may suffer from chronic kidney disease(CKD),and cardiovascular disease(CVD)is the main cause of death from chronic renal failure.Therefore,early identification of clinical manifestations of CVD and early intervention in CVD are of vital importance.Cardiac biomarkers,such as B-type natriuretic peptide(BNP)and N-terminal pro-B-type natriuretic peptide(NT-proBNP),are commonly used to diagnose congestive heart failure(CHF)in symptomatic patients.There is sufficient evidence that these biomarkers can be used to assess the severity of the disease and its prognosis.However,in CKD patients,because the decrease of renal clearance rate may affect the plasma level of these biomarkers,BNP faces challenges in diagnosis utility and prognosis evaluation.It is difficult to distinguish cardiac-induced heart failure from renal-induced chronic BNP elevation in non-dialysis CKD patients.This review reviews the physiological functions of the natriuretic peptide BNP in detail,and briefly discusses the characteristics of CVD in a non-dialysis CKD population,the changes of BNP,influencing factors and possible mechanisms,and its predictive significance for CVD.http://www.lcszb.com/thesisDetails?columnId=57906140&Fpath=home&index=0Chronic kidney diseaseB-type natriuretic peptideCardiovascular diseaseInfluencing factorsMechanism
spellingShingle WANG Xiao-yu
XU Mi-qing
An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
Linchuang shenzangbing zazhi
Chronic kidney disease
B-type natriuretic peptide
Cardiovascular disease
Influencing factors
Mechanism
title An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
title_full An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
title_fullStr An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
title_full_unstemmed An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
title_short An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
title_sort applied study of b type natriuretic peptide in a non dialysis population with chronic kidney disease
topic Chronic kidney disease
B-type natriuretic peptide
Cardiovascular disease
Influencing factors
Mechanism
url http://www.lcszb.com/thesisDetails?columnId=57906140&Fpath=home&index=0
work_keys_str_mv AT wangxiaoyu anappliedstudyofbtypenatriureticpeptideinanondialysispopulationwithchronickidneydisease
AT xumiqing anappliedstudyofbtypenatriureticpeptideinanondialysispopulationwithchronickidneydisease
AT wangxiaoyu appliedstudyofbtypenatriureticpeptideinanondialysispopulationwithchronickidneydisease
AT xumiqing appliedstudyofbtypenatriureticpeptideinanondialysispopulationwithchronickidneydisease